EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Synthaverse's enterprise value is zł417.41 Mil.
Synthaverse's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was zł60.51 Mil. Therefore, Synthaverse's EV-to-Revenue for today is 6.90.
The historical rank and industry rank for Synthaverse's EV-to-Revenue or its related term are showing as below:
WAR:SVE'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.69 Med: 4.53 Max: 37.58
Current: 6.9
During the past 13 years, the highest EV-to-Revenue of Synthaverse was 37.58. The lowest was 0.69. And the median was 4.53.
WAR:SVE's EV-to-Revenue is ranked better than 53.13% of 1037
companies
in the Biotechnology industry
Industry Median: 7.86
vs WAR:SVE: 6.90
As of today (2024-06-08), Synthaverse's stock price is zł5.00.
Synthaverse's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.86. Therefore, Synthaverse's PS Ratio for today is 5.81.
Synthaverse EV-to-Revenue Historical Data
The historical data trend for Synthaverse's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Synthaverse's EV-to-Revenue
For the Biotechnology subindustry, Synthaverse's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthaverse's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synthaverse's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Synthaverse's EV-to-Revenue falls into.
Synthaverse's current Enterprise Value is zł417.41 Mil.
Synthaverse's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł60.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthaverse's share price for today is zł5.00.
Synthaverse's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthaverse EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Synthaverse's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WAR:SVE has been successfully added to your 